Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostics Laboratory, |
RCV001171318 | SCV001334048 | likely pathogenic | Interstitial lung disease 2 | 2019-01-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003769842 | SCV004625744 | likely pathogenic | not provided | 2023-05-17 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with pulmonary surfactant metabolism dysfunction (PMID: 32532878). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 915844). This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 961 of the ABCA3 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the ABCA3 protein. |